[1] |
SUN Zhao-gang.
Attention should be paid to the research and development of Mycobacterium tuberculosis antigen detection technology
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 120-124.
|
[2] |
LIU Li-qin, XU Zu-hui, HUANG Yi-sheng, YAO Qi-neng, TAN Yun-hong, ZHOU Lin, XIA Yin-yin, LIU Er-yong, HUANG Guo-jun, BAI Li-qiong, CHENG Shi-ming.
Study on the clinical efficacy of a 4-month treatment program for the initial treatment of smear-negative pulmonary tuberculosis with Mycobacterium vaccae Vaccine immune intervention
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 125-130.
|
[3] |
LIU Yuan, CHEN Jie, SUN Hui, LIU Xing, LIU Meng-xing, LI Chi-chuan, YANG Bai-rong, YANG Min.
Exploration of the drug use pattern of traditional Chinese medicine in the treatment of pulmonary tuberculosis and its core drug action mechanism
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 131-140.
|
[4] |
YAO Li-ming, DONG Zhao-liang, YAO Xiao-wei, WANG Lian-bo, JIA Chen-guang, LI Zhuo, LIU Feng-sheng.
Clinical study on one-stage focal debridement and total hip replacement for treating active hip tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 147-152.
|
[5] |
LIU Xiao-yu, XU Feng, ZHOU Yi-ming, DAI Xi-yong, SHENG Jian, JIANG Yu-hui, LIU Qi-bin, SHEN Lei.
Effect of fiberboard stripping by uniportal video-assisted thoracic surgery in the treatment of tuberculous empyema
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 153-158.
|
[6] |
JIN Long, TIAN Qi, ZHANG Bao-qing, XING Hai-dong, GAO Ming-xia, ZHANG Xiu-ying, WANG Li-hua, ZHANG Xiao-lei.
Research of effectiveness of fluorescence PCR melting curve assay in detecting drug resistance of levofloxacin and moxifloxacin in patients with multidrug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 159-163.
|
[7] |
WANG Shao-hua, ZHAO Guo-lian, WANG Pei, TAN Xiao-wen, CUI Xiao-li, KANG Lei, DANG Li-yun.
Analysis of inconsistency between genotypic and phenotypic results of Mycobacterium tuberculosis rifampicin susceptibility test
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 169-173.
|
[8] |
ZHANG Can-you, CHEN Hui, FA Li-feng, ZHANG Hui, CHENG Jun.
Evaluation of the effects of tuberculosis infection control training courses in China, 2016-2019
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 174-180.
|
[9] |
CHEN Jing, XIAO Xiao, WU Zhe-yuan, RAO Li-xin, WANG Juan, ZHANG Xia, SHEN Xin, YUAN Zheng-an.
Screening of latent infection of Mycobacterium tuberculosis and analysis of influencing factors in elderly patients with type-2 diabetic mellitus in Xuhui and Changning Districts in Shanghai
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 181-186.
|
[10] |
WANG Wei, YE Yi-nong, LIN Dong-zi, ZHONG Qian-hong, HUANG Fei, DU Fang-fang, CHENG Shi-ming, ZHOU Jie, ZHANG Xi-lin, ZHONG Qiu.
Analysis of epidemiological characteristics of rifampicin resistance tuberculosis in Foshan City, Guangdong Province, 2011-2020
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 187-192.
|
[11] |
HAN Ting-ting, CHEN Qiu-qi, DENG Guo-fang.
The research progress of 3-gene host transcriptional biomarkers (GBP5, DUSP3 and KLF2)
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 193-196.
|
[12] |
ZHOU Qian-ru, WANG Ling-hua.
Research progress on related factors of depression tendency in patients with multidrug resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 197-202.
|
[13] |
ZHOU Ting-ting, ZHENG Xiao-man, OUYANG Jing, LU Yan-qiu, CHEN Yao-kai.
Research progress on genes and mechanism of Mycobacterium tuberculosis resistance to pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 102-105.
|
[14] |
YANG Yang, YUAN Yuan, LU Shui-hua.
Preliminary study on the clinical characteristics of 41 children with retreated drug-sensitive tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 106-109.
|
[15] |
HAO Xiao-gang, WANG Wei, ZHANG Xing, ZHU Ping, XU Chun-feng.
Study on the implementation of using electronic medicine box to assist drug taking management of pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 110-112.
|